Sinopharm Plans Share Repurchase Mandate Vote

Sinopharm Group Co (HK:1099) has released an update.

Sinopharm Group Co. Ltd. has announced a domestic shareholders’ meeting to occur on June 13, 2024, where a special resolution will be considered to grant the Board a general mandate to repurchase up to 10% of the H Shares in issue. The repurchase plan includes a range of actions such as determining the repurchase price, opening overseas share accounts, and possibly canceling the repurchased shares or holding them as treasury shares.

For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.